BRIEF published on 12/11/2025 at 07:05, 7 days 11 hours ago Innate Pharma reveals its 2026 financial calendar Biotechnology Financial Calendar Immunotherapy Innate Pharma 2026 Results
BRIEF published on 12/11/2025 at 07:05, 7 days 11 hours ago Innate Pharma Announces 2026 Financial Calendar Biotechnology Investor Information Innate Pharma Financial Schedule 2026 Key Dates
PRESS RELEASE published on 12/11/2025 at 07:00, 7 days 11 hours ago Inside Information / Other news releases Innate Pharma releases its 2026 financial calendar, including key dates for financial statements and shareholder meetings. Find details on the company's website Euronext Financial Calendar Nasdaq Innate Pharma 2026
BRIEF published on 11/28/2025 at 07:05, 20 days 11 hours ago New number of shares and voting rights of Innate Pharma Euronext Paris Share Capital Nasdaq Innate Pharma Shares And Rights
BRIEF published on 11/17/2025 at 07:05, 1 month 1 day ago Innate Pharma to Present at Jefferies Global Healthcare Conference Biotechnology Immunotherapy Innate Pharma Jefferies Conference Antibody Therapeutics
PRESS RELEASE published on 11/17/2025 at 07:00, 1 month 1 day ago Inside Information / Other news releases Innate Pharma to present at Jefferies Global Healthcare Conference on November 17, 2025. A global biotechnology company focusing on cancer immunotherapies Biotechnology Immunotherapy Cancer Innate Pharma Jefferies Global Healthcare Conference
BRIEF published on 10/14/2025 at 07:05, 2 months 4 days ago Innate Pharma Highlights Lacutamab at Analyst and Investor Event Investors Clinical Trial Innate Pharma Lacutamab Sézary Syndrome
PRESS RELEASE published on 10/14/2025 at 07:00, 2 months 4 days ago Inside Information / Other news releases Innate Pharma to host analyst and investor event on Lacutamab on October 28, 2025. Event includes clinical perspectives, market outlook, and updates on Phase 3 trial and regulatory pathway for lacutamab Phase 3 Trial Investor Event Regulatory Pathway Innate Pharma Lacutamab
BRIEF published on 09/10/2025 at 10:35, 3 months 8 days ago Innate Pharma Announces 2025 Half-Year Results Conference Call Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
PRESS RELEASE published on 09/10/2025 at 10:30, 3 months 8 days ago Inside Information / Other news releases Innate Pharma schedules conference call and webcast for first half 2025 financial results and business update. Details for participation available on the company's website Financial Results Conference Call Business Update Webcast Innate Pharma
Published on 12/18/2025 at 15:00, 3 hours 30 minutes ago Vox Royalty Acquires Feasibilty-Stage Stockman Copper-Gold Royalty in Australia
Published on 12/18/2025 at 14:31, 3 hours 59 minutes ago Worksport Reports Highest Monthly Revenue in Company History
Published on 12/18/2025 at 14:00, 4 hours 30 minutes ago Route1 Announces Provisional Patent Application
Published on 12/18/2025 at 14:00, 4 hours 30 minutes ago LQR House Announces $6.52 Million Registered Direct Offering
Published on 12/18/2025 at 18:00, 29 minutes ago Wicomico County Selects Waga Energy to Upgrade Landfill Gas to RNG in Maryland
Published on 12/18/2025 at 17:45, 44 minutes ago ENOGIA: ENOGIA selected to supply South Korea’s first fully privately financed waste-heat-to-power project on a fuel cell plant
Published on 12/18/2025 at 17:40, 49 minutes ago LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 30 november 2025.
Published on 12/18/2025 at 17:40, 49 minutes ago VALBIOTIS SA: Valbiotis recognized by the 2025 Top Santé Award for Valbiotis Plus® Serenity, an innovative solution for emotional balance
Published on 12/18/2025 at 16:31, 1 hour 59 minutes ago In Brazil, ENGIE Fully Commissions Serra do Assuruá, Its Largest Wind Complex Worldwide
Published on 12/17/2025 at 20:39, 21 hours 50 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 18:00, 1 day ago Outstanding Shares and Voting Rights Statement at 30 November 2025
